Gene · 3205
Papers4,255
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 4,255
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinical Characteristics and Prognosis of Adult Acute Myeloid Leukemia with NUP98 Gene Rearrangement]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2021 | 34627423 | PubTator, text mining | PubMed |
| Comparative profiling of immune genes improves the prognoses of lower grade gliomas. | Cancer Biol Med | 2021 | 34623790 | PubTator, text mining | PubMed |
| Clinical evolution, genetic landscape and trajectories of clonal hematopoiesis in SAMD9/SAMD9L syndromes. | Nat Med | 2021 | 34621053 | PubTator, text mining | PubMed |
| Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review. | World J Gastrointest Oncol | 2021 | 34616513 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion. | Cancer Res | 2021 | 34610968 | PubTator, text mining | PubMed |
| Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer. | J Clin Lab Anal | 2021 | 34606634 | PubTator, text mining | PubMed |
| N1, N12-Diacetylspermine Is Elevated in Colorectal Cancer and Promotes Proliferation through the miR-559/CBS Axis in Cancer Cell Lines. | J Oncol | 2021 | 34603448 | PubTator, text mining | PubMed |
| Transcription factor MEF2D is required for the maintenance of MLL-rearranged acute myeloid leukemia. | Blood Adv | 2021 | 34597364 | PubTator, text mining | PubMed |
| Novel MYO1D Missense Variant Identified Through Whole Exome Sequencing and Computational Biology Analysis Expands the Spectrum of Causal Genes of Laterality Defects. | Front Med (Lausanne) | 2021 | 34589502 | PubTator, text mining | PubMed |
| Analysis of genome-wide DNA methylation patterns in obesity. | Endocr J | 2021 | 34588385 | PubTator, text mining | PubMed |
| A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. | Sci Transl Med | 2021 | 34586829 | PubTator, text mining | PubMed |
| Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma. | Int J Mol Sci | 2021 | 34576110 | PubTator, text mining | PubMed |
| In Silico Analysis to Explore Lineage-Independent and -Dependent Transcriptional Programs Associated with the Process of Endothelial and Neural Differentiation of Human Induced Pluripotent Stem Cells. | J Clin Med | 2021 | 34575270 | PubTator, text mining | PubMed |
| NSD1: A Lysine Methyltransferase between Developmental Disorders and Cancer. | Life (Basel) | 2021 | 34575025 | PubTator, text mining | PubMed |
| SALL4 and microRNA: The Role of Let-7. | Genes (Basel) | 2021 | 34573282 | PubTator, text mining | PubMed |
| Splice and Dice: Intronic microRNAs, Splicing and Cancer. | Biomedicines | 2021 | 34572454 | PubTator, text mining | PubMed |
| Stationed or Relocating: The Seesawing EMT/MET Determinants from Embryonic Development to Cancer Metastasis. | Biomedicines | 2021 | 34572451 | PubTator, text mining | PubMed |
| Research Progress on the Functions and Mechanism of circRNA in Cisplatin Resistance in Tumors. | Front Pharmacol | 2021 | 34566636 | PubTator, text mining | PubMed |
| Combinatorial CRISPR/Cas9 Screening Reveals Epistatic Networks of Interacting Tumor Suppressor Genes and Therapeutic Targets in Human Breast Cancer. | Cancer Res | 2021 | 34561273 | PubTator, text mining | PubMed |
| Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression. | Nat Genet | 2021 | 34556857 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3205/papers?page=58